Production (Stage)
D
Cartesian Therapeutics, Inc. RNAC
$10.34 $0.020.19% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Total Cash And Short-Term Investments 74.47% 176.44% 3,088.33% -- -23.17%
Total Receivables -59.67% -90.15% 367.71% -- --
Inventory -- -- -- -- --
Prepaid Expenses -3.12% -36.70% 7,996.08% -- --
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets 66.61% 138.76% 2,705.29% -- --

Total Current Assets 66.61% 138.76% 2,705.29% -- --
Net Property, Plant & Equipment 29.83% 26.81% 2,022.25% -- --
Long-term Investments 0.00% 0.00% -- -- --
Goodwill 0.00% 0.00% -- -- --
Total Other Intangibles 0.00% 0.00% -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 460.78% 58.82% 6,576.00% -- --
Total Assets 25.81% 42.61% 4,789.56% -- --

Total Accounts Payable -16.69% -90.86% -- -- --
Total Accrued Expenses -2.92% -22.67% 541.36% -- --
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current 66.17% 31.63% 914.65% -- --
Total Finance Division Other Current Liabilities -97.69% -82.31% 1,247.26% -- --
Total Other Current Liabilities -97.69% -82.31% 1,247.26% -- --
Total Current Liabilities -59.08% -66.32% 808.92% -- --

Total Current Liabilities -59.08% -66.32% 808.92% -- --
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases 25.94% 26.67% 1,499.06% -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities 2.12% 10.89% -- -- --
Total Liabilities -2.51% -0.64% 14,572.82% -- --

Common Stock & APIC 23.84% 285.28% 8,505.84% -- --
Retained Earnings -5.71% -12.60% -1,915.54% -- --
Treasury Stock & Other 0.35% -0.46% -- -- --
Total Common Equity 81.35% 98.45% 102.91% -- -224.48%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 81.35% 98.45% 102.91% -- -224.48%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 81.35% 95.13% -87.90% -- -224.48%